carmofur has been researched along with Biliary Tract Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akaishi, S | 1 |
| Kobari, M | 1 |
| Yusa, T | 1 |
| Yamanami, H | 1 |
| Furukawa, T | 1 |
| Matsuno, S | 1 |
1 other study available for carmofur and Biliary Tract Cancer
| Article | Year |
|---|---|
[Transfer of carmofur (HCFU) to the serum, bile, pancreatic juice and pancreatic tumor tissue in the cases of peri-pancreatic head cancer].
Topics: Administration, Oral; Antineoplastic Agents; Bile; Biliary Tract Neoplasms; Fluorouracil; Humans; Pa | 1995 |